Posteroperative cardiovascular complications after major abdominal surgery
Conditions
Interventions
Group 1: Data of patients after major abdominal surgery will be collected on audit standards and confounding factors for risk-adjusted analyses.
These include age, sex, ethnicity, body mass index, Am
Sponsors
Universitätsklinikum Heidelberg Chirurgische Klinik - CHIRNet SIGMA Study Group
Eligibility
Sex/Gender
All
Age
19 Years to No maximum
Inclusion criteria
Inclusion criteria: -Age: Adult, 18 years or above. -Procedure: Major abdominal surgery, including one or more of the following: --Visceral resection, defined as complete transection and removal of a segment of the oesophagus, stomach, small bowel, liver, pancreas, gallbladder, colon, appendix, rectum, kidney, bladder, ovary and/or uterus, including multivisceral resections. --Formation and reversal of stoma (ileostomy,colostomyorurostomy). --Open repair of abdominal aortic aneurysm or vascular bypass procedure with abdominal component. --Anterior abdominal wall incisional hernia or parastomal hernia repair. --Transplant surgery, including renal, liver or pancreas surgery. -Approach: Open, laparoscopic, laparoscopic assisted, laparoscopic converted, robotic, robotic converted procedures are all eligible. -Urgency: Patients undergoing planned (elective or expedited) or unplanned (emergency) surgery.
Exclusion criteria
Exclusion criteria: -Procedures: --Groin (femoral, inguinal), umbilical or paraumbilical hernia repairs and other abdominal and/or pelvic surgeries without resection (e.g. anti-reflux surgery, rectopexy, sterilisation) are excluded. --Caesarean sections (C-sections) are excluded. --Bariatric procedures (i.e., sleeve gastrectomy, gastric bypass) are excluded. --Diagnostic laparoscopy or laparotomy without resection are excluded. --Laparoscopic appendicectomy and laparoscopic cholecystectomy that did not require open conversion are excluded. --Transanal, transurethral, transvaginal procedures without an abdominal incision are excluded. -Indication: Procedures performed for a trauma indication (blunt or penetrating) are excluded. -Pregnancy: pregnant patients (positive urine or blood hCG test prior to surgery) are excluded. -Minor surgery: Planned day case procedures (discharge home on the same day as surgery) are excluded. -Extent of surgery: We will exclude operations that are either: --Staged with a planned return for reoperation (such as but not limited to damage control laparotomy or burns surgery) OR --Change inoperative plan such that during the first procedure it is determined that a reoperation is necessary, even if the patient was enrolled preoperatively -Return to theatre: Each individual patient should only be included in the study once. Patients returning to theatre due to complications following earlier surgery can be included, as long as their indexed procedure has not already been included in the CASCADE audit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To audit compliance to pre-, intra-, and postoperative audit standards in reducing risk of postoperative cardiovascular complication. | — |
Secondary
| Measure | Time frame |
|---|---|
| -To characterise rates and risk factors associated with postoperative cardiovascular complications following major abdominal surgery in Europe. -To explore the association of pre-operative and postoperative anaemia with postoperative cardiovascular complications and short-term outcomes (length of stay, readmission and 30-day mortality). -To characterise the efficacy and safety profile of extended pharmacological thromboprophylaxis in patients at high risk for VTE. | — |
Countries
Albania, Austria, Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Finland, Germany, Greece, Hungary, Ireland, Italy, Kosovo, Lithuania, Malta, Netherlands, Poland, Portugal, Romania, Russia, Serbia, Slovenia, Spain, Switzerland, Turkey, United Kingdom
Outcome results
None listed